Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life
Objective: Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess th...
Saved in:
Published in | Journal of diabetes science and technology Vol. 18; no. 4; pp. 911 - 919 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Los Angeles, CA
SAGE Publications
01.07.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1932-2968 1932-3107 |
DOI | 10.1177/19322968221139873 |
Cover
Loading…
Abstract | Objective:
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.
Methods:
Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration–approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.
Results:
Participants’ (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.
Conclusion:
Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes. |
---|---|
AbstractList | Objective:
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.
Methods:
Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration–approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.
Results:
Participants’ (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.
Conclusion:
Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes. Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.OBJECTIVEReal-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D.Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.METHODSAdolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data.Participants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.RESULTSParticipants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM (P = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior.Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes.CONCLUSIONReal-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes. Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has not been assessed in adolescents and young adults (AYAs) with T2D. The objective of this pilot interventional study was to assess the feasibility and acceptability of real-time CGM use in AYAs with T2D. Adolescents and young adults (13-21 years old) with T2D for six months or more and hemoglobin A1c (A1c) greater than 7%, on any Food and Drug Administration-approved treatment regimen, were included. After a blinded run-in period, participants were given access to a real-time CGM system for 12 weeks. The use and acceptability of the real-time CGM were evaluated by sensor usage, surveys, and focus group qualitative data. Participants' (n = 9) median age was 19.1 (interquartile range [IQR] 16.8-20.5) years, 78% were female, 100% were people of color, and 67% were publicly insured. Baseline A1c was 11.9% (standard deviation ±2.8%), with median diabetes duration of 2.5 (IQR 1.4-6) years, and 67% were using insulin. Seven participants completed the study and demonstrated statistically significant improvement in diabetes-related quality of life, with the mean Pediatric Quality of Life inventory (PedsQL) diabetes score increasing from 70 to 75 after using CGM ( = .026). Focus group results supported survey results that CGM use among AYAs with T2D is feasible, can improve quality of life, and has the potential to modify behavior. Real-time CGM is feasible and acceptable for AYAs with T2D and may improve the quality of life of patients with diabetes. Larger randomized controlled trials are needed to assess the effects on glycemic control and healthy lifestyle changes. |
Author | Puckett, Cassidy Gitelman, Stephen E. Wong, Jenise C. Srinivasan, Shylaja Chesser, Hannah |
AuthorAffiliation | 2 Department of Sociology, Emory University, Atlanta, GA, USA 1 Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA |
AuthorAffiliation_xml | – name: 2 Department of Sociology, Emory University, Atlanta, GA, USA – name: 1 Division of Endocrinology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA |
Author_xml | – sequence: 1 givenname: Hannah orcidid: 0000-0002-0724-4310 surname: Chesser fullname: Chesser, Hannah – sequence: 2 givenname: Shylaja surname: Srinivasan fullname: Srinivasan, Shylaja – sequence: 3 givenname: Cassidy surname: Puckett fullname: Puckett, Cassidy – sequence: 4 givenname: Stephen E. surname: Gitelman fullname: Gitelman, Stephen E. – sequence: 5 givenname: Jenise C. orcidid: 0000-0003-0573-6650 surname: Wong fullname: Wong, Jenise C. email: jenise.wong@ucsf.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36416098$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi3Uin7AD-CCfOSSEn8ktk9otYVSaVEFWoQ4WU4y3rpy7CV2Kvbfk2i3VQGpJ1sz7_vO6JkzdBRiAITekPKCECHeE8UoVbWklBCmpGAv0OlcKxgpxdHhPwtO0FlKd2VZcSnES3TCak7qUslT9PsbGF-sXQ94GUN2YYxjwld-bGMC_CUGl-Pgwga7gBdd9JBaCDlhEzr8M45TY9GNfir8cPkWr3dbwBRfOtNAhoSXJuDrfjvEe8BfR-Nd3uFo8cpZeIWOrfEJXh_ec_T908f18nOxurm6Xi5WRcuZykVjjKyAMWaJVJY3VtREckOrqiKMl4IxUdGuBstrRaGR0rZGWFV1raklV4Sdow_73O3Y9NDN2w_G6-3gejPsdDRO_90J7lZv4r2ekJaCsjnh3SFhiL9GSFn3bqLgvQkwwdJUMMUZ4WU9Sd8-HfY45YH3JCB7QTvElAawjxJS6vmm-r-bTh7xj6d12WQX532df9Z5sXcmswF9F8chTKifMfwBgVGyGA |
CitedBy_id | crossref_primary_10_1177_26350106231205030 crossref_primary_10_1177_19322968231178284 crossref_primary_10_3390_children10030516 crossref_primary_10_1007_s40200_024_01403_9 crossref_primary_10_1111_1753_0407_13454 crossref_primary_10_1111_dom_15328 crossref_primary_10_1186_s13690_024_01459_2 crossref_primary_10_1038_s41574_024_00973_1 crossref_primary_10_1089_dia_2023_0268 crossref_primary_10_2337_dc25_S014 crossref_primary_10_1089_dia_2024_0539 crossref_primary_10_2337_dc25_S007 crossref_primary_10_1016_j_ecl_2025_02_018 crossref_primary_10_1155_2023_1979635 crossref_primary_10_1007_s00125_024_06203_7 |
Cites_doi | 10.2337/dc18-1581 10.1093/jpepsy/jsx146 10.2337/dci19-0028 10.1111/ijpo.12846 10.1089/dia.2018.0177 10.3945/jn.116.246058 10.2337/dc21-S013 10.1001/archinternmed.2009.193 10.1111/nyas.14270 10.1056/NEJMoa2100165 10.2337/dc21-S007 10.1089/15209150050214131 10.1210/jc.2016-2534 10.2337/dc16-1066 10.1016/S0140-6736(17)31371-5 10.1016/j.jbi.2008.08.010 10.1556/2006.2020.00053 10.1210/clinem/dgab896 10.1001/jama.2021.11165 10.2337/dc11-1438 10.1177/1932296821997851 10.1007/s11892-017-0905-0 10.1016/j.diabres.2008.06.015 10.1210/jc.2014-3612 10.1016/j.dsx.2020.07.051 10.1016/j.dsx.2019.07.054 10.7326/M16-2855 10.1089/dia.2019.0303 10.2337/dc09-1502 10.3390/ijerph17228479 10.1016/S0140-6736(17)32461-3 10.1001/jama.2021.6530 10.1210/jc.2010-2756 10.1093/jpepsy/27.1.47 10.1057/978-1-137-58614-8 10.1093/jamia/ocx025 10.4158/EP161392.CS 10.7326/0003-4819-157-5-201209040-00508 10.2337/dc09-0108 10.1177/1357633X20972911 10.1123/pes.9.4.342 10.2337/dc10-1989 10.1186/s13098-020-00584-6 10.3390/nu12061583 10.1177/160940690900800301 10.2337/dc17-1600 10.1111/dme.13841 10.1136/bmj.d3805 10.1056/NEJMoa052187 10.1016/j.jdiacomp.2016.10.007 10.2196/jmir.6382 10.4103/jpbs.JPBS_7_20 |
ContentType | Journal Article |
Copyright | 2022 Diabetes Technology Society 2022 Diabetes Technology Society 2022 Diabetes Technology Society |
Copyright_xml | – notice: 2022 Diabetes Technology Society – notice: 2022 Diabetes Technology Society 2022 Diabetes Technology Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1177/19322968221139873 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1932-3107 |
EndPage | 919 |
ExternalDocumentID | PMC11307231 36416098 10_1177_19322968221139873 10.1177_19322968221139873 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: K23 DK120932 – fundername: NIDDK NIH HHS grantid: T32 DK007161 |
GroupedDBID | --- -TM 0R~ 53G 54M AABMB AACMV AACTG AADCB AADUE AAEWN AAGLT AAGMC AAJPV AAKGS AANEX AAQXI AARDL AARIX AATAA AATBZ AAUAS ABAWP ABCCA ABCJG ABEIX ABFWQ ABIDT ABJIS ABJNI ABJZC ABKRH ABLUO ABPNF ABQXT ABRHV ABUJY ABVFX ACARO ACDSZ ACDXX ACFEJ ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLZU ACOFE ACOXC ACROE ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADDVE ADEBD ADNON ADRRZ ADVBO ADZZY AECGH AEDTQ AEKYL AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXNY AFEET AFKRG AFMOU AFQAA AFUIA AGHKR AGKLV AGNHF AGPXR AGWFA AHDMH AJUZI AJXAJ ALJHS ALKWR ALMA_UNASSIGNED_HOLDINGS AMCVQ ANDLU AOIJS ARTOV AUTPY AYAKG B8M BAWUL BBRGL BDDNI BKIIM BKSCU BPACV BSEHC BWJAD C45 CDWPY CFDXU DC- DC. DIK DOPDO DV7 E3Z EBS EJD EMOBN F5P FHBDP GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GX1 H13 HYE J8X K.F O9- OK1 OVD P2P P6G ROL RPM SASJQ SAUOL SCNPE SFC SFH SHG SJN SPQ SPV TEORI TR2 ZONMY ZPPRI ZRKOI ZSSAH AAYXX AJGYC CITATION AAPII AJVBE CGR CUY CVF ECM EIF NPM 7X8 5PM AJHME |
ID | FETCH-LOGICAL-c439t-baa85e333f189f4bf76184a25551340733752d6ef4692eb88fca7f95dca684913 |
ISSN | 1932-2968 |
IngestDate | Thu Aug 21 18:31:52 EDT 2025 Fri Jul 11 12:08:41 EDT 2025 Mon Jul 21 06:01:12 EDT 2025 Thu Apr 24 22:55:24 EDT 2025 Tue Jul 01 00:49:40 EDT 2025 Tue Jun 17 22:31:30 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | lifestyle factors sensors type 2 diabetes continuous glucose monitoring adolescents pediatrics |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c439t-baa85e333f189f4bf76184a25551340733752d6ef4692eb88fca7f95dca684913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0573-6650 0000-0002-0724-4310 |
OpenAccessLink | https://escholarship.org/content/qt7w308878/qt7w308878.pdf |
PMID | 36416098 |
PQID | 2739431406 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11307231 proquest_miscellaneous_2739431406 pubmed_primary_36416098 crossref_primary_10_1177_19322968221139873 crossref_citationtrail_10_1177_19322968221139873 sage_journals_10_1177_19322968221139873 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-07-01 |
PublicationDateYYYYMMDD | 2024-07-01 |
PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Los Angeles, CA |
PublicationPlace_xml | – name: Los Angeles, CA – name: United States – name: Sage CA: Los Angeles, CA |
PublicationTitle | Journal of diabetes science and technology |
PublicationTitleAlternate | J Diabetes Sci Technol |
PublicationYear | 2024 |
Publisher | SAGE Publications |
Publisher_xml | – name: SAGE Publications |
References | Kowalski, Crocker, Kowalski 1997; 9 Bergenstal, Beck, Close 2018; 41 Alessi, de Oliveira, Franco 2020; 12 Pickup, Freeman, Sutton 2011; 343 Heary, Hennessy 2002; 27 Flaudias, Iceta, Zerhouni 2020; 9 Lawrence, Divers, Isom 2021; 326 Danne, Nimri, Battelino 2017; 40 Harris, Taylor, Thielke, Payne, Gonzalez, Conde 2009; 42 Vigersky, Fonda, Chellappa, Walker, Ehrhardt 2012; 35 Onwuegbuzie, Dickinson, Leech, Zoran 2009; 8 McGavock, Wicklow, Dart 2017 1829; 390 Varni, Delamater, Hood 2019; 36 Dhaliwal, Pereira, Diaz-Thomas, Powe, Yanes Cardozo, Joseph 2022; 107 Yeh, Brown, Maruthur 2012; 157 Peters, Ahmann, Battelino 2016; 101 Azhar, Gillani, Mohiuddin, Majeed 2020; 12 Shapiro, Vesco, Weil, Evans, Hood, Weissberg-Benchell 2018; 43 Battelino, Danne, Bergenstal 2019; 42 Klonoff, Buckingham, Christiansen 2011; 96 Langendam, Luijf, Hooft, Devries, Mudde, Scholten 2012; 1 Nearchou, Flinn, Niland, Subramaniam, Hennessy 2020; 17 Nadeau, Anderson, Berg 2016; 39 Pintus, Ng 2019; 13 Burkart, Parker, Weaver 2022; 17 2020; 44 Karter, Parker, Moffet, Gilliam, Dlott 2021; 325 Nathan, Zinman, Cleary 2009; 169 Beck, Hirsch, Laffel 2009; 32 2010; 33 Alshareef, Al Zahrani, Alzahrani, Ghandoura 2020; 14 2021; 44 Haynes, Kompala, Neinstein, Rosenthal, Crossen 2021; 15 Thornton, Kumanyika, Gregg 2020; 1461 Battelino, Phillip, Bratina, Nimri, Oskarsson, Bolinder 2011; 34 Beck, Riddlesworth, Ruedy 2017; 167 Park, Le 2018; 20 Fonseca, Grunberger, Anhalt 2016; 22 Thompson, Midthune, Kahle, Dodd 2017; 147 Vigersky, Shrivastav 2017; 31 Nathan, Cleary, Backlund 2005; 353 Alvarado, Kum, Gonzalez Coronado, Foster, Ortega, Lawley 2017; 19 Chan, Pyle, Newnes, Nadeau, Zeitler, Kelsey 2015; 100 Chan 2017; 17 Viner, White, Christie 2017; 389 Ammar, Brach, Trabelsi 2020; 12 Haynes, Marcin, Dayal, Tancredi, Crossen 2020; 0 Boland, Tamborlane 2000; 2 Heitkemper, Mamykina, Travers, Smaldone 2017; 24 Anderson, Gavin, Kruger 2020; 22 Yoo, An, Park 2008; 82 Bjornstad, Drews 2021; 385 bibr9-19322968221139873 bibr21-19322968221139873 bibr47-19322968221139873 bibr19-19322968221139873 bibr14-19322968221139873 bibr27-19322968221139873 bibr41-19322968221139873 bibr54-19322968221139873 bibr34-19322968221139873 Langendam M (bibr11-19322968221139873) 2012; 1 bibr13-19322968221139873 bibr33-19322968221139873 bibr39-19322968221139873 bibr26-19322968221139873 bibr46-19322968221139873 bibr3-19322968221139873 bibr40-19322968221139873 bibr20-19322968221139873 bibr15-19322968221139873 bibr50-19322968221139873 bibr25-19322968221139873 bibr5-19322968221139873 bibr4-19322968221139873 bibr45-19322968221139873 bibr35-19322968221139873 bibr55-19322968221139873 bibr44-19322968221139873 bibr6-19322968221139873 bibr37-19322968221139873 bibr1-19322968221139873 bibr17-19322968221139873 bibr31-19322968221139873 bibr24-19322968221139873 bibr51-19322968221139873 bibr49-19322968221139873 bibr23-19322968221139873 bibr16-19322968221139873 bibr29-19322968221139873 bibr36-19322968221139873 bibr30-19322968221139873 bibr43-19322968221139873 bibr10-19322968221139873 bibr28-19322968221139873 bibr18-19322968221139873 bibr53-19322968221139873 bibr2-19322968221139873 bibr12-19322968221139873 bibr7-19322968221139873 bibr42-19322968221139873 bibr52-19322968221139873 bibr32-19322968221139873 bibr22-19322968221139873 bibr8-19322968221139873 bibr38-19322968221139873 bibr48-19322968221139873 |
References_xml | – volume: 36 start-page: 465 issue: 4 year: 2019 end-page: 472 article-title: Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for youth with Type 2 diabetes: reliability and validity publication-title: Diabet Med – volume: 167 start-page: 365 issue: 6 year: 2017 end-page: 374 article-title: Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections publication-title: Ann Intern Med – volume: 17 start-page: e12846 issue: 1 year: 2022 article-title: Impact of the COVID-19 pandemic on elementary schoolers’ physical activity, sleep, screen time and diet: a quasi-experimental interrupted time series study publication-title: Pediatr Obes – volume: 343 start-page: d3805 year: 2011 article-title: Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data publication-title: BMJ – volume: 107 start-page: 1205 issue: 5 year: 2022 end-page: 1215 article-title: Eradicating racism: an endocrine society policy perspective publication-title: J Clin Endocrinol Metab – volume: 39 start-page: 1635 issue: 9 year: 2016 end-page: 1642 article-title: Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities publication-title: Diabetes Care – volume: 100 start-page: 902 issue: 3 year: 2015 end-page: 910 article-title: Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth publication-title: J Clin Endocrinol Metab – volume: 17 start-page: 66 issue: 9 year: 2017 article-title: Use of continuous glucose monitoring in youth-onset type 2 diabetes publication-title: Curr Diab Rep – volume: 34 start-page: 795 issue: 4 year: 2011 end-page: 800 article-title: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes publication-title: Diabetes Care – volume: 42 start-page: 377 issue: 2 year: 2009 end-page: 381 article-title: Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support publication-title: J Biomed Inform – volume: 101 start-page: 3922 issue: 11 year: 2016 end-page: 3937 article-title: Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society Clinical Practice Guideline publication-title: J Clin Endocrinol Metab – volume: 35 start-page: 32 issue: 1 year: 2012 end-page: 38 article-title: Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes publication-title: Diabetes Care – volume: 40 start-page: 1631 issue: 12 year: 2017 end-page: 1640 article-title: International consensus on use of continuous glucose monitoring publication-title: Diabetes Care – volume: 82 start-page: 73 issue: 1 year: 2008 end-page: 79 article-title: Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes publication-title: Diabetes Res Clin Pract – volume: 385 start-page: 416 issue: 5 year: 2021 end-page: 426 article-title: Long-term complications in youth-onset type 2 diabetes publication-title: N Engl J Med – volume: 325 start-page: 2273 issue: 22 year: 2021 end-page: 2284 article-title: Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes publication-title: JAMA – volume: 8 start-page: 1 issue: 3 year: 2009 end-page: 21 article-title: A qualitative framework for collecting and analyzing data in focus group research publication-title: Int J Qual Methods – volume: 1461 start-page: 5 issue: 1 year: 2020 end-page: 24 article-title: New research directions on disparities in obesity and type 2 diabetes publication-title: Ann N Y Acad Sci – volume: 32 start-page: 1378 issue: 8 year: 2009 end-page: 1383 article-title: The effect of continuous glucose monitoring in well-controlled type 1 diabetes publication-title: Diabetes Care – volume: 353 start-page: 2643 issue: 25 year: 2005 end-page: 2653 article-title: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes publication-title: N Engl J Med – volume: 31 start-page: 280 issue: 1 year: 2017 end-page: 287 article-title: Role of continuous glucose monitoring for type 2 in diabetes management and research publication-title: J Diabetes Complications – volume: 96 start-page: 2968 issue: 10 year: 2011 end-page: 2979 article-title: Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline publication-title: J Clin Endocrinol Metab – volume: 12 start-page: 76 year: 2020 article-title: Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing publication-title: Diabetol Metab Syndr – volume: 24 start-page: 1024 issue: 5 year: 2017 end-page: 1035 article-title: Do health information technology self-management interventions improve glycemic control in medically underserved adults with diabetes? a systematic review and meta-analysis publication-title: J Am Med Inform Assoc – volume: 326 start-page: 717 issue: 8 year: 2021 end-page: 727 article-title: Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017 publication-title: JAMA – volume: 9 start-page: 342 issue: 4 year: 1997 end-page: 352 article-title: Convergent validity of the physical activity questionnaire for adolescents publication-title: Pediatr Exerc Sci – volume: 14 start-page: 1583 issue: 5 year: 2020 end-page: 1587 article-title: Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia publication-title: Diabetes Metab Syndr – volume: 19 start-page: e28 issue: 2 year: 2017 article-title: Barriers to remote health interventions for type 2 diabetes: a systematic review and proposed classification scheme publication-title: J Med Internet Res – volume: 44 start-page: S180 year: 2021 end-page: S199 article-title: 13. Children and adolescents: standards of medical care in diabetes—2021 publication-title: Diabetes Care – volume: 13 start-page: 2923 issue: 5 year: 2019 end-page: 2926 article-title: Freestyle libre flash glucose monitoring improves patient quality of life measures in children with Type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals publication-title: Diabetes Metab Syndr – volume: 22 start-page: 169 issue: 3 year: 2020 end-page: 173 article-title: Current eligibility requirements for CGM coverage are harmful, costly, and unjustified publication-title: Diabetes Technol Ther – volume: 33 start-page: 17 issue: 1 year: 2010 end-page: 22 article-title: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial publication-title: Diabetes Care – volume: 12 start-page: E1583 issue: 6 year: 2020 article-title: Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 international online survey publication-title: Nutrients – volume: 157 start-page: 336 issue: 5 year: 2012 end-page: 347 article-title: Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis publication-title: Ann Intern Med – volume: 15 start-page: 986 issue: 5 year: 2021 end-page: 992 article-title: Disparities in telemedicine use for subspecialty diabetes care during COVID-19 shelter-in-place orders publication-title: J Diabetes Sci Technol – volume: 9 start-page: 826 issue: 3 year: 2020 end-page: 835 article-title: COVID-19 pandemic lockdown and problematic eating behaviors in a student population publication-title: J Behav Addict – volume: 12 start-page: 102 issue: 2 year: 2020 end-page: 111 article-title: A systematic review on clinical implication of continuous glucose monitoring in diabetes management publication-title: J Pharm Bioallied Sci – volume: 0 issue: 0 year: 2020 article-title: Impact of telemedicine on visit attendance for paediatric patients receiving endocrinology specialty care publication-title: J Telemed Telecare – volume: 44 start-page: S85 year: 2020 end-page: 99 article-title: 7. Diabetes technology: standards of medical care in diabetes—2021 publication-title: Diabetes Care – volume: 41 start-page: 2275 issue: 11 year: 2018 end-page: 2280 article-title: Glucose management indicator (GMI): a new term for estimating A1c from continuous glucose monitoring publication-title: Diabetes Care – volume: 389 start-page: 2252 issue: 10085 year: 2017 end-page: 2260 article-title: Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden publication-title: The Lancet – volume: 1 start-page: CD008101 year: 2012 article-title: Continuous glucose monitoring systems for type 1 diabetes mellitus publication-title: Cochrane Database Syst Rev – volume: 17 start-page: 8479 issue: 22 year: 2020 article-title: Exploring the impact of COVID-19 on mental health outcomes in children and adolescents: a systematic review publication-title: Int J Environ Res Public Health – volume: 169 start-page: 1307 issue: 14 year: 2009 end-page: 1316 article-title: Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005) publication-title: Arch Intern Med – volume: 2 start-page: S53 year: 2000 end-page: S59 article-title: Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment publication-title: Diabetes Technol Ther – volume: 27 start-page: 47 issue: 1 year: 2002 end-page: 57 article-title: The use of focus group interviews in pediatric healthcare research publication-title: J Pediatr Psychol – volume: 22 start-page: 1008 issue: 8 year: 2016 end-page: 1021 article-title: Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology publication-title: Endocr Pract – volume: 147 start-page: 1226 issue: 6 year: 2017 end-page: 1233 article-title: Development and evaluation of the National Cancer Institute’s dietary screener questionnaire scoring algorithms publication-title: J Nutr – volume: 43 start-page: 561 issue: 5 year: 2018 end-page: 571 article-title: Psychometric properties of the problem areas in diabetes: teen and parent of teen versions publication-title: J Pediatr Psychol – volume: 390 issue: 10105 year: 2017 1829 article-title: Type 2 diabetes in youth is a disease of poverty publication-title: The Lancet – volume: 42 start-page: 1593 issue: 8 year: 2019 end-page: 1603 article-title: Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range publication-title: Diabetes Care – volume: 20 start-page: 613 issue: 9 year: 2018 end-page: 621 article-title: The effectiveness of continuous glucose monitoring in patients with type 2 diabetes: a systematic review of literature and meta-analysis publication-title: Diabetes Technol Ther – volume: 1 start-page: CD008101 year: 2012 ident: bibr11-19322968221139873 publication-title: Cochrane Database Syst Rev – ident: bibr30-19322968221139873 doi: 10.2337/dc18-1581 – ident: bibr33-19322968221139873 doi: 10.1093/jpepsy/jsx146 – ident: bibr29-19322968221139873 doi: 10.2337/dci19-0028 – ident: bibr42-19322968221139873 doi: 10.1111/ijpo.12846 – ident: bibr15-19322968221139873 doi: 10.1089/dia.2018.0177 – ident: bibr32-19322968221139873 doi: 10.3945/jn.116.246058 – ident: bibr27-19322968221139873 doi: 10.2337/dc21-S013 – ident: bibr6-19322968221139873 doi: 10.1001/archinternmed.2009.193 – ident: bibr50-19322968221139873 doi: 10.1111/nyas.14270 – ident: bibr7-19322968221139873 doi: 10.1056/NEJMoa2100165 – ident: bibr24-19322968221139873 doi: 10.2337/dc21-S007 – ident: bibr25-19322968221139873 doi: 10.1089/15209150050214131 – ident: bibr22-19322968221139873 doi: 10.1210/jc.2016-2534 – ident: bibr3-19322968221139873 doi: 10.2337/dc16-1066 – ident: bibr2-19322968221139873 doi: 10.1016/S0140-6736(17)31371-5 – ident: bibr28-19322968221139873 doi: 10.1016/j.jbi.2008.08.010 – ident: bibr43-19322968221139873 doi: 10.1556/2006.2020.00053 – ident: bibr51-19322968221139873 – ident: bibr53-19322968221139873 doi: 10.1210/clinem/dgab896 – ident: bibr1-19322968221139873 doi: 10.1001/jama.2021.11165 – ident: bibr17-19322968221139873 doi: 10.2337/dc11-1438 – ident: bibr48-19322968221139873 doi: 10.1177/1932296821997851 – ident: bibr4-19322968221139873 doi: 10.1007/s11892-017-0905-0 – ident: bibr16-19322968221139873 doi: 10.1016/j.diabres.2008.06.015 – ident: bibr26-19322968221139873 doi: 10.1210/jc.2014-3612 – ident: bibr38-19322968221139873 doi: 10.1016/j.dsx.2020.07.051 – ident: bibr41-19322968221139873 doi: 10.1016/j.dsx.2019.07.054 – ident: bibr18-19322968221139873 doi: 10.7326/M16-2855 – ident: bibr54-19322968221139873 doi: 10.1089/dia.2019.0303 – ident: bibr9-19322968221139873 doi: 10.2337/dc09-1502 – ident: bibr40-19322968221139873 doi: 10.3390/ijerph17228479 – ident: bibr52-19322968221139873 doi: 10.1016/S0140-6736(17)32461-3 – ident: bibr19-19322968221139873 doi: 10.1001/jama.2021.6530 – ident: bibr20-19322968221139873 doi: 10.1210/jc.2010-2756 – ident: bibr36-19322968221139873 doi: 10.1093/jpepsy/27.1.47 – ident: bibr35-19322968221139873 doi: 10.1057/978-1-137-58614-8 – ident: bibr46-19322968221139873 doi: 10.1093/jamia/ocx025 – ident: bibr21-19322968221139873 doi: 10.4158/EP161392.CS – ident: bibr13-19322968221139873 doi: 10.7326/0003-4819-157-5-201209040-00508 – ident: bibr8-19322968221139873 doi: 10.2337/dc09-0108 – ident: bibr47-19322968221139873 doi: 10.1177/1357633X20972911 – ident: bibr31-19322968221139873 doi: 10.1123/pes.9.4.342 – ident: bibr10-19322968221139873 doi: 10.2337/dc10-1989 – ident: bibr39-19322968221139873 doi: 10.1186/s13098-020-00584-6 – ident: bibr44-19322968221139873 doi: 10.3390/nu12061583 – ident: bibr37-19322968221139873 doi: 10.1177/160940690900800301 – ident: bibr23-19322968221139873 doi: 10.2337/dc17-1600 – ident: bibr49-19322968221139873 – ident: bibr34-19322968221139873 doi: 10.1111/dme.13841 – ident: bibr12-19322968221139873 doi: 10.1136/bmj.d3805 – ident: bibr5-19322968221139873 doi: 10.1056/NEJMoa052187 – ident: bibr14-19322968221139873 doi: 10.1016/j.jdiacomp.2016.10.007 – ident: bibr45-19322968221139873 doi: 10.2196/jmir.6382 – ident: bibr55-19322968221139873 doi: 10.4103/jpbs.JPBS_7_20 |
SSID | ssj0054877 |
Score | 2.4709504 |
Snippet | Objective:
Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D)... Real-time continuous glucose monitoring (CGM) is effective for diabetes management in cases of type 1 diabetes and adults with type 2 diabetes (T2D) but has... |
SourceID | pubmedcentral proquest pubmed crossref sage |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 911 |
SubjectTerms | Adolescent Blood Glucose - analysis Blood Glucose Self-Monitoring Continuous Glucose Monitoring Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - psychology Feasibility Studies Female Glycated Hemoglobin - analysis Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - therapeutic use Male Original Pilot Projects Quality of Life Young Adult |
Title | Real-Time Continuous Glucose Monitoring in Adolescents and Young Adults With Type 2 Diabetes Can Improve Quality of Life |
URI | https://journals.sagepub.com/doi/full/10.1177/19322968221139873 https://www.ncbi.nlm.nih.gov/pubmed/36416098 https://www.proquest.com/docview/2739431406 https://pubmed.ncbi.nlm.nih.gov/PMC11307231 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZZB2Nfyt7nvaHBYLDiYlvyiz6WrF0ZaTc2B_LNyLZMMoJbWmds_SP9u7uTZDvG2-j2xQTFloXv0enu9NyJkDdMlbH0CuGyCiY5Z6x0hRfmbsgD6ZdcqlCHBk5Oo-M5_7gIF5PJ9RZradPk-8XVb_NK_keq0AZyxSzZf5Bs1yk0wG-QL1xBwnC9kYy_gJXnYhIHJu41q3qDfNYPloRuZuuFzVk56Cs36f0CPcuhdbNukALbLPdSE4x93wZjpzDzTchB7ZlKG3ozfraqhuyh3qLt4rhtrpBmZ45i99OlrleuFz1Z131A-ivuJn2XlzYmu_y5lt-6VeMzEkAaS1KBiVz2NFSwmtdtINeQ1mx-hY1mBLxjvrYKGOxJNxDmqJ191bcxezruWGv3IQmtgoVR3uOlQW9OY1_YfQCOLxOJOUZlWIb79FN2NJ_NsvRwkd4itwPwP_w2DGSWePTyYkNXMIO12-VYyWv0gqHBM_JixmTcLUahNnLSe2TXypIeGKjdJxNVPyB3Tiz_4iH50SGO9oijFnG0Rxxd1XQLcRSAQDXiqEEcRcRRRBwNaIs4CoijFnHUIo6eVRQR94jMjw7T6bFrz-5wCzBxGzeXMgkVY6ACElHxvIrxZCEJDmzoM44nhcZhUEaq4pEIVJ4kVSHjSoRlIaOEC589Jjv1Wa2eEgpKhsdlEquAg7kP3cX4iMgr0C5lrjyHeO0Hzgpb2B7PV1lnvq1lP5KJQ951j5ybqi5_u_l1K7UMdC9uqMlawefNwPQXYICDTeyQJ0aKXXcsAlfHE4lDkoF8uxuwrvvwn3q11PXd4b1eDH6XQ94iFDKrcS7_PMRnNxjic3K3n3AvyE5zsVEvwaBu8lca3L8AJmrI9w |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-Time+Continuous+Glucose+Monitoring+in+Adolescents+and+Young+Adults+With+Type+2+Diabetes+Can+Improve+Quality+of+Life&rft.jtitle=Journal+of+diabetes+science+and+technology&rft.au=Chesser%2C+Hannah&rft.au=Srinivasan%2C+Shylaja&rft.au=Puckett%2C+Cassidy&rft.au=Gitelman%2C+Stephen+E&rft.date=2024-07-01&rft.issn=1932-2968&rft.eissn=1932-3107&rft.volume=18&rft.issue=4&rft.spage=911&rft_id=info:doi/10.1177%2F19322968221139873&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-2968&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-2968&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-2968&client=summon |